Ovarian Dysgerminoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2013-01-17
Clinical Trial Update: Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer [Phase 2]
Termination of a Phase 2 trial of imatinib mesylate in progressive, refractory, or recurrent stage II/III testicular or ovarian germ cell tu…